Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes

Previous study reported that preadmission insulin treatment in patients with coronavirus disease 2019 (COVID-19) and concurrent diabetes was associated a significantly increased odds of mortality. However, such association may be modified by possible baseline differences glycemic control between users non-insulin users. Misinterpretation the mortality could lead to confusion clinical practice hospitalized COVID-19 for whom is appropriately indicated omitted from treatment. requirement during hospitalization marker poor prognosis as used identify patient population who require more aggressive treatments prevent